Today: 18 November 2025
Subscribe
Browse Category

Mergers & Acquisitions News 14 October 2025 - 16 October 2025

Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

COF Stock Price – Volatile October Swing Capital One’s stock has see-sawed in mid-October. It closed at $202.42 on Oct. 16, down 5.9% for the day stockanalysis.com, after a sharp afternoon sell-off. This reversal erased a short rally earlier in the week when COF climbed from ~$202 on Oct. 10 to $215.10 by Oct. 15 stockanalysis.com. Traders attribute the sudden drop to a mix of legal headlines and broader bank jitters. Notably, U.S. regional bank stocks also fell ~4% on Oct. 16 amid a credit loss surprise at Zions Bank reuters.com reuters.com, which spooked financial investors sector-wide. Despite this pullback,
16 October 2025
 ·  ·  ·  ·  ·  · 
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Stock Performance: Recent Surge and Volatility Omeros shares were trading around $4–$4.60 through early October, then exploded on Oct. 15. Data from the company’s IR site show OMER jumped from $4.10 (Oct 14 close) to $10.42 by Oct 15 close investor.omeros.com. Intraday on Oct 15, it even hit a high around $12.10. This roughly 150% one-day surge was driven by the Novo Nordisk deal (see below). Trading volume was staggering: Benzinga reports ~89.2 million shares traded (vs. a ~1.1M daily average) during the rally benzinga.com. By mid-October 16 pre-market, OMER was around $9–10 per share – still far above levels seen
16 October 2025
 ·  ·  ·  ·  ·  · 
First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

Stock Performance and Recent Trend According to market reports, FHN shares traded around $20 on Oct 15, 2025 after the selloff bloomberg.com. This was down ~13% from Wednesday’s open near $23.02 marketbeat.com. (FHN had just hit its 52-week high ~$23.63 earlier in October marketbeat.com.) The share price briefly touched an intraday low of $19.99 bloomberg.com. For perspective, that is the steepest one-day drop since regulators derailed TD Bank’s planned $13.4 billion merger with FHN in May 2023 bloomberg.com. FHN’s 50-day and 200-day moving averages were near $22.5 and $20.7 respectively marketbeat.com, so the plunge pushed the stock back towards longer-term support
16 October 2025
 ·  ·  ·  ·  · 
Shocking Surge: Hillenbrand Stock Soars 19% on $32 Buyout Announcement

Shocking Surge: Hillenbrand Stock Soars 19% on $32 Buyout Announcement

Lone Star Buyout Details Hillenbrand (NYSE: HI) announced on Oct. 15 that it will be acquired by Lone Star Funds in an all-cash deal at $32.00 per share ir.hillenbrand.com. At this price, the transaction’s enterprise value is roughly $3.8 billion, including Hillenbrand’s debt. The board said it reviewed multiple strategic options and unanimously determined the offer “is in the best interest of Hillenbrand and its shareholders” ir.hillenbrand.com. Lone Star’s offer represents a 37% premium to Hillenbrand’s pre-deal share price on Aug. 12 ir.hillenbrand.com, and 53% above the 90-day average price up to that date. The companies expect the deal to close by
15 October 2025
 ·  ·  ·  ·  · 
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Novo Nordisk Licensing Deal Sparks Rally On Oct. 15, Novo Nordisk (NYSE: NVO) and Omeros announced a landmark deal licensing zaltenibart (OMS906), Omeros’s experimental MASP-3 inhibitor for rare blood/kidney diseases investor.omeros.com. Under the agreement, Novo pays $340M upfront and can pay up to $2.1 billion in total milestones and royalties for exclusive global rights investor.omeros.com reuters.com. Reuters reports that Omeros stock “more than doubled to $9.90” in early trading after the news reuters.com, and by market close had settled near $10.10 investing.com. TechStock² (ts2.tech) notes Omeros shares surged roughly 65% on the announcement ts2.tech. The deal is structured as an
15 October 2025
 ·  ·  ·  ·  ·  · 
Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340 million up front and near-term milestones, plus up to $2.1 billion total with development and sales milestones and tiered royalties novonordisk.com. Reuters reported Novo would pay “up to $2.1 billion” for the experimental drug reuters.com. The deal is structured as a licensing asset purchase, not a full acquisition, and is expected to close in Q4 2025 marketscreener.com novonordisk.com. Novo’s Chief Scientific
15 October 2025
 ·  ·  ·  ·  ·  ·  · 
Nuclear SPAC Stock Skyrockets on Merger Frenzy: HOND Shares Soar as Terrestrial Energy Deal Nears

Nuclear SPAC Stock Skyrockets on Merger Frenzy: HOND Shares Soar as Terrestrial Energy Deal Nears

HOND stock has surged into the mid-$20s (around $24.98 as of Oct. 15, 2025) after trading in the high teens last week investing.com marketbeat.com. Its volume spiked (about 1.14 million shares on Oct. 13) and the stock gapped up from $18.86 to $21.69 at open on Oct. 13 marketbeat.com. – The catalyst is a proposed merger with Terrestrial Energy Inc., a next-gen nuclear reactor company. The SEC declared the merger’s S-4 registration effective on Sept. 26, and HCM II shareholders will vote on Oct. 20 to approve the deal businesswire.com businesswire.com. If approved, the combined firm will list on Nasdaq
15 October 2025
 ·  ·  ·  ·  · 
Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Merger with Flash Sports & Media Sparks Stock Surge Urban-gro’s announcement of a planned merger with Flash Sports & Media sent its battered stock soaring on October 14. The company revealed it signed a binding LOI to combine with Flash, a private sports-media firm, in what is effectively a reverse merger tipranks.com. Under the proposal, Flash will be absorbed into new Urban-gro subsidiaries, and Flash’s shareholders will receive new Urban-gro shares (unregistered) equal to 19.99% of UGRO’s pre-merger common stock, plus a new series of preferred shares that convert to common upon shareholder approval sec.gov sec.gov. Once the dust settles,
14 October 2025
 ·  ·  ·  ·  · 
Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?

Astria Therapeutics Stock Skyrockets 53% After $700M Buyout – What’s Next?

Latest News & Developments On Oct. 14, 2025, Astria was swept into the headlines by a surprise $700+ million takeover. BioCryst Pharmaceuticals announced a definitive merger agreement to acquire Astria for $8.55 in cash plus 0.59 shares of BioCryst stock per Astria share (≈$13.00 total) marketscreener.com reuters.com. This values Astria at roughly $920M equity and $700M enterprise stocktitan.net. The Boards of both companies approved the deal, which is expected to close in Q1 2026 (subject to approvals) stocktitan.net. Astria CEO Jill Milne will join BioCryst’s board post-merger stocktitan.net. Market reaction: News of the deal caused Astria’s stock to jump sharply.
14 October 2025
 ·  ·  ·  ·  ·  · 
BlackRock’s GIP Poised for $38B AES Power Grab – AI-Fuelled Demand Sparks Takeover Frenzy

BlackRock Soars: Crypto ETFs, AI Funds and Mega M&A Propel Assets to Record $13.5T

BlackRock’s latest earnings and moves underscore its market heft and broad strategy. CEO Larry Fink observed that “record demand” across the firm’s businesses — from technology-driven funds to private credit and ETFs — powered the quarter reuters.com. In particular, strong flows into lower-cost index and cash products (helped by the Fed’s recent rate cut) drove the fee bump. An analyst noted that all of BlackRock’s new private-market businesses (HPS, Preqin, GIP) “made healthy contributions” to Q3 results reuters.com, validating BlackRock’s aggressive M&A in 2025. Larry Fink said the unified public-private platform positions BlackRock well for what he expects will be
14 October 2025
 ·  ·  ·  ·  ·  ·  · 
EasyJet Stock Skyrockets on Takeover Rumours – MSC Denies Interest

EasyJet Stock Skyrockets on Takeover Rumours – MSC Denies Interest

What’s Happening? On Oct 14 an Italian newspaper (Corriere della Sera) reported that MSC, the world’s largest container-ship operator, is exploring a bid for EasyJet. The report said MSC might team up with an investment fund to buy a stake or even full control of the UK airline proactiveinvestors.com marketscreener.com. In early London trading EasyJet stock soared (hitting 11.5% gains) on the news reuters.com. By late morning the jump had eased to mid-single digits, especially after MSC publicly denied the rumours. MSC’s emailed statement – “MSC denies any involvement in this matter” – was picked up by Reuters and dampened
14 October 2025
 ·  ·  ·  · 
PMGC Holdings (ELAB) Shares Skyrocket 230% Amid Acquisition Spree – What’s Next?

PMGC Holdings (ELAB) Shares Skyrocket 230% Amid Acquisition Spree – What’s Next?

Company Overview PMGC Holdings Inc. (NASDAQ: ELAB) is a diversified holding company that grows by acquisitions. Its profile describes it as managing a portfolio of subsidiaries through strategic deals reuters.com. Notably, one subsidiary – NorthStrive Biosciences – is a biopharma/medtech firm developing aesthetic and obesity-related treatments (e.g. an engineered probiotic “EL-22” for muscle retention) reuters.com. The other arms (PMGC Research, PMGC Capital) provide R&D and investment vehicles. However, PMGC’s recent focus is industrial: it seeks cash-flow positive U.S.-based manufacturing businesses (CNC machining, packaging, etc.) to bolt onto its platform sec.gov tipranks.com. In Jan 2025 the company sold its former skincare
14 October 2025
 ·  ·  ·  · 
1 … 7 8 9 10 11 12
Go toTop